– Proteomics International Laboratories (ASXIQ) was flat at 50c after the medtech company announced the publication of two studies validating its predictive test for diabetic kidney disease. The results form a basis for regulatory approvals related to its PromarkerD test and its adoption by pathology laboratories worldwide, Proteomics said.
Ann: PromarkerD clinical assay performance results published, page-21
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.015(1.57%) |
Mkt cap ! $127.0M | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | 99.5¢ | 96.3¢ | $64.34K | 65.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15200 | 96.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.0¢ | 22247 | 2 |
View Market Depth
| Last trade - 15.58pm 16/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |